In another investigation, NKG2D-DAP10-CD3ζ-CAR-NK cells exhibited a robust antitumor immune response against HCC cell lines of HCC as well as osteosarcoma, pancreatic cancer, and breast cancer [207]. Here, KLRK1 is linked to hepatocellular carcinoma.